On June 16, the 24th CPHI China (CPHI China 2026) officially opened at the Shanghai New International Expo Centre. This three-day trade event for the pharmaceutical industry brings together hundreds of thousands of professional visitors and thousands of exhibitors from over 180 countries and regions, providing an international platform for exchange, technological innovation, and business matchmaking across the pharmaceutical supply chain. Hebei Messi Biology Co., Ltd. participated with its comprehensive range of high-end magnesium salt products and technologies at Booth W8D38. With its technical foundation, product portfolio, and integrated supply chain, the company attracted notable attention at the exhibition.
Established in 1989, Hebei Messi Biology Co., Ltd. is a national science and technology enterprise and a “Specialized, Refined, Unique and Innovative” (SRDI) enterprise of Hebei Province, with over 30 years of experience in the magnesium salt sector. The company specializes in the R&D, production, and sales of magnesium salts, including magnesium oxide, magnesium carbonate, magnesium sulfate, and magnesium hydroxide. These products are widely used in key areas such as pharmaceuticals, food, and biological preparations, aligning closely with the exhibition’s focus on the pharmaceutical supply chain. Supported by hydromagnesite resources and a vertically integrated “mining-smelting-deep processing” industrial layout, the company has established a stable raw material supply chain. Its subsidiary, Tibet Meide Technology Co., Ltd., holds a multi-million-ton hydromagnesite mineral resource and is equipped with a 10,000-ton high-end powder deep-processing production line, helping ensure product quality and supply stability from the source.
At the exhibition, Hebei Messi Biology Co., Ltd. highlighted three core categories of magnesium salts: pharmaceutical grade, food grade, and high-purity nano-grade. Among them, the pharmaceutical-grade magnesium oxide, magnesium carbonate, magnesium sulfate, and magnesium hydroxide can achieve a purity of up to 99.9%. Supported by several self-developed production patents, these products are suitable for various applications such as pharmaceutical excipients, formulation raw materials, and pharmaceutical intermediates. Produced in compliance with GMP standards, they have obtained international certifications including ISO9001, FSSC22000, and US FDA registration, with quality meeting international standards. The food-grade magnesium salts, designed for the food and dietary supplement sectors, serve as nutrient fortifiers, anti-caking agents, and filter aids, recognized by domestic and international food and pharmaceutical enterprises for their safety and stable performance. Additionally, the company offers customized magnesium salt products tailored to individual customer requirements to meet diverse needs across the pharmaceutical supply chain.
The Messi Biology booth at W8D38 attracted steady visitor traffic, with pharmaceutical companies, buyers, and industry experts from home and abroad stopping by for inquiries. The company’s exhibition team welcomed visitors, providing detailed introductions to product performance, technical advantages, customized solutions, and global cooperation models. They also engaged in discussions regarding the technical iteration, application innovation, and market cooperation of pharmaceutical magnesium materials. Several business representatives expressed preliminary cooperative intentions, laying a foundation for future collaboration.
Feng Wenjie, General Manager of Hebei Messi Biology Co., Ltd., stated that this exhibition serves as an opportunity for the company to demonstrate its capabilities and connect with the global market, while also providing a platform to learn from industry peers and seek mutual development. The pharmaceutical industry is moving toward higher quality, innovation, and green development. High-end pharmaceutical excipients, as a key component of the industrial chain, play an important role in ensuring drug quality and supporting industry upgrades. Looking ahead, Messi Biology plans to continue investing in R&D, focusing on the high-end pharmaceutical-grade magnesium salt sector, addressing technical challenges, and optimizing its product portfolio. By leveraging its integrated supply chain, quality control, and service capabilities, the company aims to provide reliable magnesium salt products and solutions to pharmaceutical enterprises worldwide.
The CPHI China 2026 exhibition will run until June 18. Hebei Messi Biology Co., Ltd. (Booth W8D38) welcomes industry colleagues from around the world to visit, discuss cooperation, explore new opportunities in the pharmaceutical industry, and work toward shared progress.